Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths': Corrigendum
| Autores principales: | ; ; |
|---|---|
| Tipo de documento: | Electrónico Artículo |
| Lenguaje: | Inglés |
| Publicado: |
2007
|
| En: |
Drug and alcohol dependence
Año: 2007, Volumen: 86, Número: 2-3, Páginas: 301 - |
| Acceso en línea: |
Volltext (lizenzpflichtig) |
| Journals Online & Print: | Gargar...
|
| Verificar disponibilidad: | HBZ Gateway |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1912489252 | ||
| 003 | DE-627 | ||
| 005 | 20250124054928.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241217s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.drugalcdep.2006.01.018 |2 doi | |
| 035 | |a (DE-627)1912489252 | ||
| 035 | |a (DE-599)KXP1912489252 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 2,1 |2 ssgn | ||
| 100 | 1 | |a Wu, Li-Tzy |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths': Corrigendum |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Galvin, Deborah M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schlenger, William E. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drug and alcohol dependence |d Amsterdam [u.a.] : Elsevier Science, 1975 |g 86(2007), 2-3, Seite 301 - |h Online-Ressource |w (DE-627)320441059 |w (DE-600)2004927-4 |w (DE-576)252887816 |x 1879-0046 |7 nnas |
| 773 | 1 | 8 | |g volume:86 |g year:2007 |g number:2-3 |g pages:301 - |
| 787 | 0 | 8 | |i Forschungsdaten |a United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies |t National Survey on Drug Use and Health, 2002 |d [Erscheinungsort nicht ermittelbar] : [Verlag nicht ermittelbar], 2004 |w (DE-627)1840045299 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.drugalcdep.2006.01.018 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 935 | |a mkri | ||
| 951 | |a AR | ||
| ELC | |a 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4637454751 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1912489252 | ||
| LOK | |0 005 20241217044239 | ||
| LOK | |0 008 241217||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-2619)ICPSR44996 | ||
| LOK | |0 040 |a DE-2619 |c DE-627 |d DE-2619 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-2619 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a nacp | ||
| ORI | |a SA-MARC-krimdoka001.raw | ||
